Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
4405 ARTÍCULOS , VIENDO DEL 976 AL 990
DeVere R.
Continuum (Minneap Minn). 2017 Apr;23(2, Selected Topics in Outpatient Neurology):421-446. doi: 10.1212/CON.0000000000000463.
Swartz RH, Cayley ML, Lanctôt KL, Murray BJ, Cohen A, Thorpe KE, Sicard MN, Lien K, Sahlas DJ, Herrmann N.
PLoS One. 2017 Apr 4;12(4):e0174451. doi: 10.1371/journal.pone.0174451. eCollection 2017.
Neuroversion: using electroconvulsive therapy as a bridge to deep brain stimulation implantation
Williams NR, Sahlem G, Pannu J, Takacs I, Short B, Revuelta G, George MS.
Neurocase. 2017 Feb;23(1):26-30. doi: 10.1080/13554794.2016.1276605. Epub 2017 Feb 7.
Magnetic resonance imaging for the diagnosis of Parkinson's disease
Heim B, Krismer F, De Marzi R, Seppi K.
J Neural Transm (Vienna). 2017 Aug;124(8):915-964. doi: 10.1007/s00702-017-1717-8. Epub 2017 Apr 4.
Multiple System Atrophy - State of the Art
Laurens B, Vergnet S, Lopez MC, Foubert-Samier A, Tison F, Fernagut PO, Meissner WG.
Curr Neurol Neurosci Rep. 2017 May;17(5):41. doi: 10.1007/s11910-017-0751-0.
Response of the cerebral vasculature following traumatic brain injury
Salehi A, Zhang JH, Obenaus A.
J Cereb Blood Flow Metab. 2017 Jul;37(7):2320-2339. doi: 10.1177/0271678X17701460. Epub 2017 Apr 5.
Nigrostriatal interaction in the aging brain: new therapeutic target for Parkinson's disease
Błaszczyk JW.
Acta Neurobiol Exp (Wars). 2017;77(1):106-112. doi: 10.21307/ane-2017-041.
Parkinson's disease and occupational exposures: a systematic literature review and meta-analyses
Gunnarsson LG, Bodin L.
Scand J Work Environ Health. 2017 May 1;43(3):197-209. doi: 10.5271/sjweh.3641. Epub 2017 Apr 5.
Back to the future: 30th anniversary of deep brain stimulation for Parkinson's disease
Pozzi NG, Pacchetti C.
Funct Neurol. 2017 Jan/Mar;32(1):5-6. doi: 10.11138/fneur/2017.32.1.005.
The Contribution of Necroptosis in Neurodegenerative Diseases
Shao L, Yu S, Ji W, Li H, Gao Y.
Neurochem Res. 2017 Aug;42(8):2117-2126. doi: 10.1007/s11064-017-2249-1. Epub 2017 Apr 5.
Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis
Wilby KJ, Johnson EG, Johnson HE, Ensom MHH.
Ann Pharmacother. 2017 Aug;51(8):682-695. doi: 10.1177/1060028017703992. Epub 2017 Apr 6.
Ribeiro GR, Campos CH, Rodrigues Garcia RCM.
J Prosthet Dent. 2017 Nov;118(5):637-642. doi: 10.1016/j.prosdent.2016.12.018. Epub 2017 Apr 3.
NR4A2 genetic variation and Parkinson's disease: Evidence from a systematic review and meta-analysis
Liu H, Liu H, Li T, Cui J, Fu Y, Ren J, Sun X, Jiang P, Yu S, Li C.
Neurosci Lett. 2017 May 22;650:25-32. doi: 10.1016/j.neulet.2017.01.062. Epub 2017 Apr 4.
Microbial Immuno-Communication in Neurodegenerative Diseases
Main BS, Minter MR.
Front Neurosci. 2017 Mar 23;11:151. doi: 10.3389/fnins.2017.00151. eCollection 2017.
A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease
Song L, Xu MB, Zhou XL, Zhang DP, Zhang SL, Zheng GQ.
Oxid Med Cell Longev. 2017;2017:2163053. doi: 10.1155/2017/2163053. Epub 2017 Mar 13.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.